Vyaire - First Cure Notice under Plan — In re Vyaire Medical, Inc., et al. (Case No. 24-11217 (BLS))
- Date
- 2025-02-24
Source document: Vyaire - First Cure Notice Under Plan; document type: Exhibit (schedule of potentially assumed executory contracts and cure amounts), 2pp.
Full text
EXHIBIT A Schedule of Potentially Assumed Contracts 1 1 The inclusion of a contract on this list does not constitute an admission as to the executory or non-executory nature of the contract, or as to the existence or validity of any claims held by the counterparty or counterparties to such contract. Case 24-11217-BLS Doc 992-1 Filed 02/24/25 Page 1 of 2 Contract Counterparty Debtor Entity Contract Description Cure Amount ComplianceQuest, Inc. Vyaire Medical Inc. Master Subscription Agreement $0.00 ComplianceQuest, Inc. Vyaire Medical Inc. Purchase Order 4201085954 $0.00 Emergo Global Consulting LLC Vyaire Medical Inc. Emergo 2018-04-30 KSA Authorized Rep Agreement $0.00 Emergo Global Consulting LLC Vyaire Medical Inc. Emergo 2019-07-03 KSA Authorized Rep Addendum $0.00 Emergo Global Consulting LLC Vyaire Medical Inc. Emergo 2020-11-16 MDR European Authorized Rep Agreement $0.00 Emergo Global Consulting LLC Vyaire Medical Inc. Emergo 2020-12-31 KSA SOW (reregister Bellavista) $0.00 Emergo Global Consulting LLC Vyaire Medical Inc. Emergo 2017-10-02 MSA Product Registration $0.00 Emergo Global Consulting LLC Vyaire Medical Inc. Emergo 2020-10-08 KSA Authorized Rep Addendum $0.00 Potentially Assumed Contracts 68877/0001-49374532v1 Case 24-11217-BLS Doc 992-1 Filed 02/24/25 Page 2 of 2
File and source
- File
- gov.uscourts.deb.193283.992.1.pdf
- Size
- 64,631 bytes
- SHA-256
- c8c8ab16daa54dc8a61b5f83c6eeffc66d35900bb41bdfd8185c9798bbee20f0
- Original
- No public link identified.